As a research-based pharmaceutical company, we focus on providing solutions to address unmet medical needs of patients around the world. We operate in a high-risk business sector - and in an age in which many countries are limiting their healthcare spending. To meet these challenges, we continue to invest in our Japanese, U.S. and European core markets, as well as emerging markets in developing and recently industrialized countries. Our diverse portfolio includes innovative and generic pharmaceuticals, vaccines, and over-the-counter medicines.
Partnerships, Licensing and Acquisitions
To expand our business and achieve long-term growth, we're partnering on high-potential products that complement our in-house portfolio. We focus our acquisition activities on new products and product candidates, and companies that drive our portfolio in key therapeutic categories. We have a special interest in biotech companies, as well as products and licenses related to the fields of oncology and cardiovascular and metabolic diseases.